Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05534646
Title Study of Apalutamide With Carotuximab in Metastatic, Castration-Resistant Prostate Cancer
Recruitment Not yet recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Edwin Posadas, MD
Indications

castration-resistant prostate carcinoma

prostate cancer

Therapies

Apalutamide

Apalutamide + Carotuximab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.